Unichem Laboratories (NSE:UNICHEMLAB) Cyclically Adjusted PB Ratio: (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
73 GF Score
Price ₹543.30
GF Value ₹688.80
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Unichem Laboratories  (NSE:UNICHEMLAB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Unichem Laboratories Cyclically Adjusted PB Ratio Related Terms


Unichem Laboratories Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Cyclically Adjusted PB Ratio Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.18 0.81

Unichem Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.35 0.00 0.81 0.00

NSE:UNICHEMLAB vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Unichem Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unichem Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unichem Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Unichem Laboratories's Cyclically Adjusted PB Ratio falls into.


NSE:UNICHEMLAB
73GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Unichem Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Unichem Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Unichem Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201303 80.379 85.687 156.990
201403 90.107 91.425 164.945
201503 97.982 97.163 168.768
201603 105.053 102.518 171.495
201703 117.039 105.196 186.198
201712 393.270 109.404 601.593
201803 381.035 109.786 580.846
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 372.236 118.202 527.033
201906 0.000 120.880 0.000
201909 363.300 123.175 493.614
201912 0.000 126.235 0.000
202003 359.536 124.705 482.506
202006 0.000 127.000 0.000
202009 356.824 130.118 458.946
202012 0.000 130.889 0.000
202103 363.156 131.771 461.232
202106 0.000 134.084 0.000
202109 355.505 135.847 437.966
202112 0.000 138.161 0.000
202203 371.902 138.822 448.348
202206 0.000 142.347 0.000
202209 361.485 144.661 418.199
202212 0.000 145.763 0.000
202303 345.894 146.865 394.158
202306 0.000 150.280 0.000
202309 342.018 151.492 377.837
202312 0.000 152.924 0.000
202403 346.320 153.035 378.733
202406 0.000 155.789 0.000
202409 340.972 157.882 361.435
202412 0.000 158.323 0.000
202503 348.066 157.552 369.729
202506 0.000 159.755 0.000
202509 345.828 162.289 356.628
202512 0.000 163.281 0.000
202603 385.967 164.272 393.215
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹543.30 is trading 21.1% below its estimated GF Value™ of ₹688.80. GuruFocus considers Unichem Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹688.80 vs. price of ₹543.30 (21.1% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
73GF Score

Get the complete analysis for NSE:UNICHEMLAB

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹543.30
Price
₹688.80
GF Value